logo

North America Pharmaceutical Glass Packaging Market Size (2024 - 2029)

The North America Pharmaceutical Glass Packaging Market is experiencing growth driven by increasing consumer spending on healthcare and stringent legislation aimed at enhancing pharmaceutical quality. The United States, a key player in the global packaging market, is witnessing a rise in demand for glass packaging due to its necessity for sterile medical products. This demand is further supported by government initiatives to reduce pharmaceutical import costs, which are expected to boost the market in Canada as well. Despite the challenges posed by the cost and lightweight advantages of plastic alternatives, the need for high-quality, sterile packaging continues to propel the market's expansion.

Home Market Analysis Packaging Research Packaging Materials Research North America Pharmaceutical Glass Packaging Market Market Size

Market Size of North America Pharmaceutical Glass Packaging Industry

North America Pharmaceutical Glass Packaging Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 6.31 Billion
Market Size (2029) USD 7.66 Billion
CAGR (2024 - 2029) 3.95 %
Market Concentration Low

Major Players

North America Pharmaceutical Glass Packaging Market Major Players

*Disclaimer: Major Players sorted in no particular order

North America Pharmaceutical Glass Packaging Market Analysis

The North America Pharmaceutical Glass Packaging Market size is estimated at USD 6.31 billion in 2024, and is expected to reach USD 7.66 billion by 2029, growing at a CAGR of 3.95% during the forecast period (2024-2029).

The United States is one of the major packaging markets globally, and many vital players produce glass containers for pharmaceuticals. As the economy continuously grows, increasing consumer spending on healthcare and medicines drives the demand for glass packaging solutions.

  • The rise in the usage of glass for pharmaceutical packaging is attributed to the advent of strict legislation designed to improve the integrity and quality of pharmaceuticals produced domestically. The pharmaceutical industry's growing need for sterile medical packaging products is anticipated to fuel the market's expansion during the forecast period.
  • The United States is a dominant force in the pharmaceutical market in both consumption and development. STAT, a health-focused media outlet, projected that by 2023, the nation's spending on prescription drugs would reach USD 600 billion, a significant increase from the estimated USD 500 billion in 2019. This surge in spending is poised to bolster the demand for pharmaceutical glass packaging within the United States.
  • Amid rising concerns over costly pharmaceutical imports, the US government authorized a pilot project allowing wholesalers and pharmacists to import FDA-approved medicines from Canada. This move is poised to escalate the demand for glass pharmaceutical packaging in Canada shortly.
  • Moreover, the surging need for sterile medical packaging, particularly from the pharmaceutical sector, is set to bolster the market's growth during the forecast period. According to the projections from StatCan, in 2024, the revenue from Canada's pharmaceutical and medicine manufacturing industry is expected to reach USD 9.94 billion.
  • However, pharmaceutical glass packaging is increasingly substituted by plastic due to benefits like low cost and lightweight, which help in transportation and negate chances of accidental breakages. The need to minimize tertiary packaging of pharmaceutical products by reducing manufacturing costs is challenging the market's growth.

North America Pharmaceutical Glass Packaging Industry Segmentation

Pharmaceutical containers typically contain neutral-borosilicate glass (borosilicate glass) or soda-lime-silica (silesia glass). Borosilicate glass is characterized by a high concentration of boric oxides, aluminum oxides, and alkali oxides (alkaline earth oxides). Glass is classified according to its intended use as either Type I, Type II, or Type III.

The North American pharmaceutical glass packaging is segmented by product types (bottles, vials, ampoules, cartridges and syringes, and other products) and country (United States and Canada). The market sizes and forecasts are provided in value (USD) for all the above segments.

By Product Types
Bottles
Vials
Ampoules
Cartridges and Syringes
Other Products
By Country
United States
Canada
Need A Different Region Or Segment?
Customize Now

North America Pharmaceutical Glass Packaging Market Size Summary

The North American pharmaceutical glass packaging market is poised for steady growth, driven by the increasing demand for sterile and high-quality packaging solutions in the pharmaceutical industry. The United States, a key player in this market, benefits from its robust pharmaceutical sector and significant consumer spending on healthcare. The market's expansion is further supported by stringent regulations aimed at ensuring the integrity of pharmaceutical products, which favor the use of glass over alternative materials. Despite the rising popularity of plastic packaging due to its cost-effectiveness and lightweight properties, glass remains a preferred choice for many applications, particularly in the packaging of injectables and high-potency medications. The market is characterized by the presence of major players such as Schott AG, Corning Incorporated, and Gerresheimer AG, who are actively investing in innovation and capacity expansion to meet the growing demand.

The market's growth trajectory is also influenced by strategic initiatives and collaborations among key industry players, as well as government policies encouraging the import of FDA-approved medicines, which could boost demand in Canada. The increasing focus on sustainability and eco-friendly packaging solutions further enhances the appeal of glass packaging, aligning with consumer preferences in North America. Additionally, the market is expected to benefit from advancements in glass manufacturing technologies and the expansion of production facilities, which will support the supply of glass containers for pharmaceuticals. As the pharmaceutical industry continues to evolve, the demand for glass packaging is anticipated to rise, driven by the need for reliable and secure packaging solutions for a wide range of pharmaceutical products.

Explore More

North America Pharmaceutical Glass Packaging Market Size - Table of Contents

  1. 1. MARKET INSIGHTS

    1. 1.1 Market Overview

    2. 1.2 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.2.1 Bargaining Power of Suppliers

      2. 1.2.2 Bargaining Power of Buyers

      3. 1.2.3 Threat of New Entrants

      4. 1.2.4 Threat of Substitute Products

      5. 1.2.5 Intensity of Competitive Rivalry

    3. 1.3 Industry Value Chain Analysis

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product Types

      1. 2.1.1 Bottles

      2. 2.1.2 Vials

      3. 2.1.3 Ampoules

      4. 2.1.4 Cartridges and Syringes

      5. 2.1.5 Other Products

    2. 2.2 By Country

      1. 2.2.1 United States

      2. 2.2.2 Canada

North America Pharmaceutical Glass Packaging Market Size FAQs

The North America Pharmaceutical Glass Packaging Market size is expected to reach USD 6.31 billion in 2024 and grow at a CAGR of 3.95% to reach USD 7.66 billion by 2029.

In 2024, the North America Pharmaceutical Glass Packaging Market size is expected to reach USD 6.31 billion.

North America Pharmaceutical Glass Packaging Market Report Snapshots

North America Pharmaceutical Glass Packaging Market Size and Share Analysis - Growth Trend and Forecasts (2024-2029)